Advanced Filters
noise
Found 64,783 clinical trials

A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11

This is a randomized, double-blind, placebo controlled First in human (FIH) trial of TBD11, administered to healthy adults. The trial will be conducted in two parts. Part 1 will consist of single ascending dose (SAD) and Food effect (FE) cohorts, and Part 2 will consist of multiple ascending dose (MAD) …

19 - 55 years of age All Phase 1
P Paul A Nuzzo, M.A.

Cannabis and Opioid Use Disorder

This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

18 - 55 years of age All Phase 1
J Jason M Wilken, PT, PhD

CMT Gait, Mobility, Balance - AOFAS Grant

The overall objective of the proposed research is to begin to better understand the potential benefits and limitations of ankle -foot orthosis (AFO) use in the context of mobility and balance during gait for individuals with Charcot-Marie-Tooth disease (CMT). These benefits will be studied in comparison to those offered by …

25 - 55 years of age All Phase N/A
X Xue Yang, PhD

An Internet-based Self-help Intervention to Improve Common Mental Health Problems Among Medical Professionals

This randomized controlled trial (RCT) aims to evaluate the effectiveness of an internet-based guided self-help intervention developed based on Problem Solving Therapy, a transdiagnostic low-intensity intervention recommended by the World Health Organization, in improving medical professionals' mental health.

18 - 60 years of age All Phase N/A
K Ka Pang Chan, MBChB

Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)

Objectives: A pilot study to compare the therapeutic and safety profiles between low(2.5mg) and standard(10mg) doses of intrapleural tissue plasminogen activator(tPA) in uncontrolled pleural infection. The study design will be tested for its trialability. Hypothesis: 2.5mg tPA has comparable therapeutic efficacy and less bleeding complications to 10mg tPA. Design and …

18 years of age All Phase 2/3
L Lena Eschelbach, Ms.

Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients

The main objective of this clinical trial is to evaluate of the safety & efficacy of the Ceretrieve device within 24 hours post thrombectomy procedure. This means to assess that the use with the Ceretrieve neuro-thrombectomy device that is designed to treat acute ischemic stroke patients raises no safety concerns …

18 years of age All Phase N/A
Y You master's degree, Qi

Application of New Oropharyngeal Airway Management in Patients Undergoing Painless Gastroenteroscopy

The objective of this study was to investigate the application of new oropharyngeal airway management in patients undergoing painless gastroenteroscopy.To see if it can really solve the problem of airway obstruction during anesthesia.The incidence of hypoxia (Spo2<90%, t>10s) and severe hypoxia (Spo2<85%) during anesthesia and sedation, as well as the …

18 - 95 years of age All Phase N/A
E Elle M Wernette, PhD

The Use of Multiple Sensors to Track Sleep in Nightshift Workers

Sleep is often a challenge for nightshift workers because their work and sleep schedules are inverted. Sleep is commonly measured using actigraphy, which is the standard measure of objective sleep in the general population; however, this method has substantial limitations for nightshift workers because the standard legacy algorithms only correctly …

18 years of age All Phase N/A
Q Qibing Xie, PhD.

Safety and Efficacy Study of CC312 for Moderate to Severe SLE

This study is a randomized, double-blind, placebo-controlled Phase I clinical trial featuring single and multiple ascending doses. It is designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and preliminary efficacy of CC312 in adult patients with moderate to severe systemic lupus erythematosus (SLE).

18 - 65 years of age All Phase 1
A Amber Bagherian, MS

Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia

Acid reduction remains the most common treatment prescribed empirically by pediatric gastroenterologists for children with functional dyspepsia (FD). When acid reduction therapy fails to provide patients with a therapeutic effect, ketotifen and cromolyn, mast cell stabilizers, represent an attractive potential therapy given data implicating mast cells in the generation of …

8 - 17 years of age All Phase 3

Simplify language using AI